To monitor the evolving molecular epidemiology and genetic diversity of HIV in a country where many distinct strains cocirculate, we performed genetic analyses on sequences from 75 HIV-1-infected Cameroonians: 74 were group M and 1 was group O. Of the group M sequences, 74 were classified into the following env gp41 subtypes or recombinant forms: CRF02 (n ‫؍‬ 54), CRF09 (n ‫؍‬ 2), CRF13 (n ‫؍‬ 2), A (n ‫؍‬ 5), CRF11 (n ‫؍‬ 4), CRF06 (n ‫؍‬ 1), G (n ‫؍‬ 2), F2 (n ‫؍‬ 2), and E (n ‫؍‬ 1, CRF01), and 1 was a JG recombinant. Comparison of phylogenies for 70 matched gp41 and protease sequences showed inconsistent classifications for 18 (26%) strains. Our data show that recombination is rampant in Cameroon with recombinant viruses continuing to recombine, adding to the complexity of circulating HIV strains. This expanding genetic diversity raises public health concerns for the ability of diagnostic assays to detect these unique HIV mosaic variants and for the development of broadly effective HIV vaccines.
H
IV-1 STRAINS FROM THE WEST-CENTRAL African country of Cameroon show remarkable genetic diversity. Cameroon is the only country where all three groups of HIV-1, M, N, and O cocirculate. [1] [2] [3] Almost all the known HIV subtypes and many recombinants, including circulating recombinant forms (CRFs) CRF01, CRF02, CRF04, CRF06, CRF09, CRF11, CRF13, and numerous unique recombinants, have been described. [4] [5] [6] [7] [8] Even recombination between HIV-1 group O and M strains has been documented in Cameroon. 9, 10 It is well established that CRF02-AG and recombinants containing portions of the CRF02 genome are the most prevalent strains in Cameroon. [4] [5] [6] 11 Continued genetic characterization of HIV-1 variants in this region, where multiple subtypes, CRFs, and unique recombinant forms (URFs) cocirculate, is important for global public health issues related to this diversity. For example, these complex recombinant viruses raise concern about whether any of these divergent strains might be missed by current diagnostic assays, as well as those assays currently under development.
Between September and November 1999, blood specimens were collected from 75 HIV-1-seropositive, antiretroviral drugnaive individuals, who routinely attended the tuberculosis (TB) and sexually transmitted infections (STIs) clinics in the seaport city of Douala and the capital city of Yaoundé, Cameroon. Blood specimens were screened for HIV using the rapid Abbott Determine HIV-1/2 assay (Abbott Laboratories, Abbott Park, IL) and two enzyme immunoassays, Genscreen HIV1/2 Version 2 (Pasteur Diagnostics, Paris, France) and AXSYM HIV1/2 gO (Abbott norge as, Oslo, Norway). Results from reactive specimens were confirmed by a Western blot test, HIV Blot 2.2 (Genelabs Diagnostics, Singapore). 12 Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples by Ficoll-Hypaque gradient density, pelleted, and stored at Ϫ20°C. All individuals provided informed consent, although samples used in this study were unlinked to patient identifiers.
Viral DNA was extracted from PBMCs using the GFX TM Genomic blood DNA purification kit (Amersham Pharmacia Biotech AB, Uppsala, Sweden) or the QIAamp DNA Mini Kit (QIAGEN Inc, Valencia, CA) according to the manufacturer's instructions. The env gp41 primary gp40F1-forward/gp41R1-reverse and nested gp46F2/gp48R2 polymerase chain reaction (PCR) primers, respectively, were used for amplification of a 445-bp fragment. 13 Nested PCR amplification of the entire protease (PR) gene with outside primers DP10-forward/DP11-reverse and inside primers DP16-forward/DP17-reverse was performed as pre- (Fig. 1) , and 2 sequences were found to be phylogenetically related to CRF09 (data not shown). Similarly, of seven sequences that clustered within the G clade five were further characterized: 4 grouped with CRF11-cpx reference sequences and 1 with CRF06-cpx. From the remaining 4 Cameroonian sequences, 2 were subsubtype F2, 1 was CRF01_AE, and 1 was unclassifiable (99CM341). Further pruning analysis revealed that the unclassifiable sequence clustered significantly (Ͼ80% bootstrap value) either with subtype G if subtype J was not included in phylogenetic analysis or with subtype J when subtype G sequences were absent (data not shown). These results suggested the presence of subtype G and J components in the 99CM341 gp41 sequence. Sliding-window bootscan analysis of this sequence showed clear intersubtype recombination with elements of subtypes G at the 5Ј portion and J at the 3Ј end (Fig. 2) .
To estimate the extent of recombination involving CRFs circulating in Cameroon in 1999, we compared the env gp41 phylogenies for 70 HIV-1 group M and 1 group O sequences with the subtype/CRF designations of their PR genes (Table 1) . There was concordance between the two gene regions for the group O strain, as well as for 74% (52 of 70) of the group M strains as follows: CRF02 (67.1%, n ϭ 47), CRF11 (1.4%, n ϭ 1), CRF01 (1.4%), cm53392 (1.4%), G (1.4%), and F2 (1.4%). The remaining 18 (26%) strains had discordant phylogenies with the following 10 gp41/PR mosaic structures: CRF02/unclass (n ϭ 4), A/CRF02 (n ϭ 3), CRF13/CRF02 (n ϭ 2), CRF11/CRF02 (n ϭ 2), CRF09/CRF02 (n ϭ 2), CRF02/F2 (n ϭ 1), G/CRF02 (n ϭ 1), F2/CRF11 (n ϭ 1), CRF06/unclass (n ϭ 1), and intersubtype JG/CRF11 (n ϭ 1). Overall, parallel analysis of the two gene regions, PR at 5Ј and env gp41 at 3Ј-ends, revealed that only two (2.9%) viruses carried potentially "pure" subtypes (G and F2). Although CRFs were predominant (76%), almost 25% were unique recombinants with discordant subtype/CRF designations between PR and env gene regions. Consistent with CRF02 being the most predominant strain in Cameroon, most of the recombinant strains contained a fragment of CRF02.
Overall, our data demonstrated a broad diversity among HIV sequences from Cameroon, including gp41 and/or PR sequences from subtypes, CRFs, and URFs. Recombination is ongoing between these forms of HIV, adding to the increasing diversity in this region, and raising public health concerns about the ability of serologic and nucleic acid-based diagnostic assays to detect these complex variants of HIV. Especially since most nucleic acid assays used by blood banks for detecting recent, "window period" infections have not been thoroughly evaluated on these unique, complex forms of HIV. Studies are ongoing to evaluate Cameroonian serum or plasma samples, with at least partial subtype characterization, against a large battery of assays being used to diagnose HIV infections. The increasing genetic diversity of Cameroonian strains also presents a serious challenge for designing and developing broadly effective HIV-1 vaccines. Finally, the extensive recombination between circulating strains in Cameroon and other countries where multiple subtypes, CRFs, and URFs cocirculate continues to create a dilemma for classification of these complex forms of HIV.
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